Lakewood-Amedex Inc   Report issue

For profit Phase 2
Founded: Florida New York United States (2006)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
2016
NCT02737722
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now